Sort by
Refine Your Search
-
translational science, leveraging molecular, cellular, and animal model systems as well as patient-derived samples to uncover mechanisms of disease heterogeneity and progression and identify novel therapeutic
-
, serum, urine, and other biological samples. Integrate multi-modal datasets to uncover mechanisms underlying kidney disease progression and treatment response. Apply advanced microscopy image analysis and
-
biospecimen collections, including pancreatic tissue, cyst fluid, and serum samples from a large clinical biobank. Perform proteomic and molecular profiling to identify and validate biomarkers associated with
-
the detection of vacuum fluctuations via electro-optic sampling, incorporating realistic parameters for femtosecond few-cycle laser pulses, terahertz bandwidths, and detector electronics. (3) System Architecture
-
the genetic and developmental basis of pediatric heart disease. We analyze genetic variation in samples from patients with congenital heart defects and utilize mouse, Xenopus and cell-based models to assess
-
fluctuations via electro-optic sampling, incorporating realistic parameters for femtosecond few-cycle laser pulses, terahertz bandwidths, and detector electronics. (3) System Architecture: Define the critical
-
. Curriculum Vitae 3. Writing Sample (no more than 30 pages) 4. Three Letters of Reference Applications must be submitted via https://indiana.peopleadmin.com/postings/32048 by March 31, 2026. Additional
-
molecular biology, flow cytometry, and functional immunology assays • Work with preclinical mouse models of prostate cancer and clinical samples. • Prepare manuscripts, present at conferences, and contribute
-
Applicants should submit: 1. Cover Letter (detailing research, teaching interests, and fit with BHIM and AAADS) 2. Curriculum Vitae 3. Writing Sample (no more than 30 pages) 4. Three Letters of Reference
-
research background, career goals, and interest in position • Current CV • Contact information for two references • Writing sample (optional) Review of applications begins February 14, 2026 and continues